Form 4: Guardant Health Director Meghan V. Joyce Reports Stock Transactions
SEC Form 4 Filing
Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition and disposal of common stock and derivative securities.
Summary
- Meghan V. Joyce, a director at Guardant Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 12, 2024, Joyce acquired 5,592 shares of common stock through the exercise of restricted stock units.
- Also on June 12, 2024, Joyce disposed of 5,592 shares of common stock.
- Joyce also acquired 10,703 stock options with an exercise price of $31.84, exercisable from June 12, 2024, and expiring on June 12, 2034.
- Additionally, Joyce acquired 6,674 restricted stock units on June 12, 2024.
- Following these transactions, Joyce directly owns 10,703 shares of common stock, 10,703 stock options, and 6,674 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The acquisition of stock options and restricted stock units by a director could be seen as a positive sign of confidence in the company's future performance.
Negatives
- The disposal of 5,592 shares of common stock could be interpreted negatively, although it is likely related to the exercise of restricted stock units.
Risks
- There are no specific risks mentioned in this document, but insider transactions always carry the risk of being misinterpreted by the market.
Future Outlook
The document does not contain any specific forward-looking statements.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for directors and officers of publicly traded companies, ensuring transparency in their trading activities.
- The vesting schedules for the restricted stock units and stock options are typical, often tied to employment tenure or specific milestones.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors as it can provide insights into their confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 06/14/2023 | Original grant date of some restricted stock units, vesting one year after or at the next annual stockholders meeting, whichever is earlier. |
| 06/12/2024 | Date of the reported transactions: acquisition and disposal of common stock, acquisition of stock options and restricted stock units. |
| 06/12/2024 | Stock options vest in full on this date or the date of the next year annual stockholders meeting, whichever is earlier. |
| 06/12/2034 | Expiration date of the acquired stock options. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.